首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Effects of Enteral Nutrition on the Barrier Function of the Intestinal Mucosa and Dopamine Receptor Expression in Rats With Traumatic Brain Injury
【24h】

Effects of Enteral Nutrition on the Barrier Function of the Intestinal Mucosa and Dopamine Receptor Expression in Rats With Traumatic Brain Injury

机译:肠内营养对颅脑外伤大鼠肠黏膜屏障功能和多巴胺受体表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Impaired intestinal mucosal barrier (IMB) function is common in traumatic brain injury (TBI), but dopamine receptors (DRs) change in intestinal mucosa after TBI, and effects of enteral nutrition (EN) and supplements on IMB function remain unclear. Our purpose was to study the effects of EN and supplements on intestinal mucosal permeability (IMPB) and the expression of DRs DRD1 and DRD2 in the intestinal mucosa of rats with TBI. Methods: Forty-eight rats were divided into 8 groups; control, animals with TBI, dopamine group, animals with TBI treated with dopamine antagonist, EN alone, or EN combined with glutamine, probiotics, or a combination of probiotics and glutamine daily after TBI. Results: The IMPB was improved in the glutamine, probiotics, and combination groups. Including probiotics improved IMPB more than adding glutamine, and bacterial translocation in the intestines after TBI was reduced in the probiotics and combination groups (all Ps < .01). TBI led to elevated DRD1 and DRD2 mRNA and protein levels, which were reduced in the DA antagonist, glutamine, probiotics, and combination groups. DRD2 mRNA and protein levels in the probiotics and combination groups were decreased more than in the DA antagonist group (all Ps < .01). The increased IMPB after TBI correlated with increased DRD1 and DRD2 levels in the rat intestinal mucosa. Conclusion: EN supplemented with probiotics or combining glutamine and probiotics lowers the increased IMPB, bacterial translocation, and DRD1 and DRD2 mRNA and protein expression in rat intestinal mucosa caused by TBI.
机译:背景:肠黏膜屏障功能受损(IMB)在颅脑外伤(TBI)中很常见,但在TBI后肠黏膜中多巴胺受体(DRs)发生变化,肠内营养(EN)和补品对IMB功能的影响尚不清楚。我们的目的是研究EN和补品对TBI大鼠肠粘膜通透性(IMPB)以及DRs DRD1和DRD2表达的影响。方法:48只大鼠分为8组。对照组,具有TBI的动物,多巴胺组,多巴胺拮抗剂,单独使用EN或EN联合谷氨酰胺,益生菌或益生菌和谷氨酰胺的组合治疗的TBI动物。结果:谷氨酰胺,益生菌和组合组的IMPB有所改善。益生菌和联合用药组中TBI降低后,包括益生菌比添加谷氨酰胺对改善IMPB的作用更大,并且肠道细菌移位(所有Ps <.01)。 TBI导致DRD1和DRD2 mRNA和蛋白水平升高,在DA拮抗剂,谷氨酰胺,益生菌和联合治疗组中降低。益生菌和联合用药组中的DRD2 mRNA和蛋白水平比DA拮抗剂组降低更多(所有Ps <.01)。 TBI后IMPB的增加与大鼠肠粘膜中DRD1和DRD2水平的增加有关。结论:补充益生菌或谷氨酰胺和益生菌联合使用的EN可以降低由TBI引起的大鼠肠粘膜中IMPB,细菌易位以及DRD1,DRD2 mRNA和蛋白表达的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号